In situ generated aza-π-allylpalladium zwitterions as nucleophilic triggers for enantioselective [4 + 2] cycloaddition with electron-deficient alkenes toward functionalized chiral piperidines
Organic Chemistry Frontiers · 2025 · 12 (4) · 1115-1121
DOI: 10.1039/d4qo02058h ↗Kurz gefasst
Fachartikel in der Zeitschrift Organic Chemistry Frontiers, 2025. Verfasst von Han-Yang Zhong und 6 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Aza-π-allylpalladium zwitterions, in situ generated from methylene cyclic carbamates, are used as nucleophilic triggers for enantioselective [4 + 2] cycloaddition with electron-deficient alkenes, affording structurally diverse chiral piperidines.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhong, H., Xiao, H., Liu, J., Ge, Z., Zhao, J., Zhou, M., & Yuan, W. (2025). In situ generated aza-π-allylpalladium zwitterions as nucleophilic triggers for enantioselective [4 + 2] cycloaddition with electron-deficient alkenes toward functionalized chiral piperidines. Organic Chemistry Frontiers, 12(4), 1115-1121. https://doi.org/10.1039/d4qo02058h
Vancouver
Zhong H, Xiao H, Liu J, Ge Z, Zhao J, Zhou M, et al. In situ generated aza-π-allylpalladium zwitterions as nucleophilic triggers for enantioselective [4 + 2] cycloaddition with electron-deficient alkenes toward functionalized chiral piperidines. Organic Chemistry Frontiers. 2025;12(4):1115-1121. doi:10.1039/d4qo02058h
BibTeX
@article{Zhong2025,
author = {Zhong, Han-Yang and Xiao, Hong-Wei and Liu, Ji-Hong and Ge, Zhen-Zhen and Zhao, Jian-Qiang and Zhou, Ming-Qiang and Yuan, Wei-Cheng},
title = {In situ generated aza-π-allylpalladium zwitterions as nucleophilic triggers for enantioselective [4 + 2] cycloaddition with electron-deficient alkenes toward functionalized chiral piperidines},
journal = {Organic Chemistry Frontiers},
year = {2025},
volume = {12},
number = {4},
pages = {1115--1121},
doi = {10.1039/d4qo02058h}
}
EUVIMED